BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 33220180)

  • 21. Cancer driver mutations in protein kinase genes.
    Torkamani A; Verkhivker G; Schork NJ
    Cancer Lett; 2009 Aug; 281(2):117-27. PubMed ID: 19081671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic alterations and DNA repair in human carcinogenesis.
    Dixon K; Kopras E
    Semin Cancer Biol; 2004 Dec; 14(6):441-8. PubMed ID: 15489137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation.
    Brosseau JP; Liao CP; Wang Y; Ramani V; Vandergriff T; Lee M; Patel A; Ariizumi K; Le LQ
    Nat Commun; 2018 Nov; 9(1):5014. PubMed ID: 30479396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. One hundred years of somatic mutation theory of carcinogenesis: is it time to switch?
    Soto AM; Sonnenschein C
    Bioessays; 2014 Jan; 36(1):118-20. PubMed ID: 24323923
    [No Abstract]   [Full Text] [Related]  

  • 25. Exploring the Role of Clustered Mutations in Carcinogenesis and Their Potential Clinical Implications in Cancer.
    Li Y; Zhu R; Jin J; Guo H; Zhang J; He Z; Liang T; Guo L
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutant Clones in Adjacent Normal Epithelium Limit Early Tumorigenesis.
    Cancer Discov; 2021 Dec; 11(12):2958. PubMed ID: 34686529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TERT promoter mutations and telomeres during tumorigenesis.
    Lorbeer FK; Hockemeyer D
    Curr Opin Genet Dev; 2020 Feb; 60():56-62. PubMed ID: 32163830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. KRAS mutation and epithelial-macrophage interplay in pancreatic neoplastic transformation.
    Bishehsari F; Zhang L; Barlass U; Preite NZ; Turturro S; Najor MS; Shetuni BB; Zayas JP; Mahdavinia M; Abukhdeir AM; Keshavarzian A
    Int J Cancer; 2018 Oct; 143(8):1994-2007. PubMed ID: 29756386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ectopic overexpression of Nanog induces tumorigenesis in non-tumorous fibroblasts.
    Park YS; Nemeño JG; Choi NY; Lee JI; Ko K; Choi SC; Kim WS; Han DW; Tapia N; Ko K
    Biol Chem; 2016 Mar; 397(3):249-55. PubMed ID: 26733157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Half or more of the somatic mutations in cancers of self-renewing tissues originate prior to tumor initiation.
    Tomasetti C; Vogelstein B; Parmigiani G
    Proc Natl Acad Sci U S A; 2013 Feb; 110(6):1999-2004. PubMed ID: 23345422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [p53 mutations and their role in tumorigenesis].
    Tsuchida N; Munirajan AK
    Tanpakushitsu Kakusan Koso; 1997 Jul; 42(10 Suppl):1567-75. PubMed ID: 9279083
    [No Abstract]   [Full Text] [Related]  

  • 32. Snapshot: genetic mouse models of cancer.
    Zender L; Zuber J; Lowe SW
    Cell; 2007 May; 129(4):838. PubMed ID: 17512415
    [No Abstract]   [Full Text] [Related]  

  • 33. SOX4: Joining the Master Regulators of Epithelial-to-Mesenchymal Transition?
    Lourenço AR; Coffer PJ
    Trends Cancer; 2017 Aug; 3(8):571-582. PubMed ID: 28780934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A cancer theory kerfuffle can lead to new lines of research.
    Baker SG
    J Natl Cancer Inst; 2015 Feb; 107(2):. PubMed ID: 25528755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mediator subunit 23 overexpression as a novel target for suppressing proliferation and tumorigenesis in hepatocellular carcinoma.
    Guo Y; Wang J; Li H; Liu W; Chen D; Zhao K; Liang X; Zhang Q; Yang Y; Chen G
    J Gastroenterol Hepatol; 2015 Jun; 30(6):1094-103. PubMed ID: 25684393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Somatic clonal evolution: A selection-centric perspective.
    Scott J; Marusyk A
    Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):139-150. PubMed ID: 28161395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dysregulated Wnt signalling and recurrent mutations of the tumour suppressor RNF43 in early gastric carcinogenesis.
    Min BH; Hwang J; Kim NK; Park G; Kang SY; Ahn S; Ahn S; Ha SY; Lee YK; Kushima R; Van Vrancken M; Kim MJ; Park C; Park HY; Chae J; Jang SS; Kim SJ; Kim YH; Kim JI; Kim KM
    J Pathol; 2016 Nov; 240(3):304-314. PubMed ID: 27514024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The potential role of nucleophosmin (NPM1) in the development of cancer.
    Karimi Dermani F; Gholamzadeh Khoei S; Afshar S; Amini R
    J Cell Physiol; 2021 Nov; 236(11):7832-7852. PubMed ID: 33959979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does aneuploidy cause cancer?
    Weaver BA; Cleveland DW
    Curr Opin Cell Biol; 2006 Dec; 18(6):658-67. PubMed ID: 17046232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutant GTF2I induces cell transformation and metabolic alterations in thymic epithelial cells.
    Kim IK; Rao G; Zhao X; Fan R; Avantaggiati ML; Wang Y; Zhang YW; Giaccone G
    Cell Death Differ; 2020 Jul; 27(7):2263-2279. PubMed ID: 32034314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.